Literature DB >> 4952445

Guillain-Barré disease complex. A statement of diagnostic criteria and analysis of 100 cases.

H R McFarland, G L Heller.   

Abstract

Mesh:

Year:  1966        PMID: 4952445     DOI: 10.1001/archneur.1966.00470080080012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  11 in total

1.  Impaired joint mobility in Guillain-Barré syndrome: a primary or a secondary phenomenon?

Authors:  I Soryal; E Sinclair; J Hornby; B Pentland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

2.  Prognostic significance of electrodiagnostic studies in the Guillain-Barré syndrome.

Authors:  P T Raman; G M Taori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-02       Impact factor: 10.154

3.  Guillain-Barré syndrome: the unsolved cardiovascular problems.

Authors:  C P Bredin
Journal:  Ir J Med Sci       Date:  1977-09       Impact factor: 1.568

4.  [Adrenalitis inclusio-necroticans in the Landry-Guillain-Barré-Syndrome].

Authors:  F W Spaar; H Orthner
Journal:  Dtsch Z Nervenheilkd       Date:  1968

5.  Guillain-Barré syndrome associated with typhoid fever.

Authors:  D Chanmugam; A Waniganetti
Journal:  Br Med J       Date:  1969-01-11

6.  "Complications" of the Landry-Guillain-Barré-Strohl syndrome.

Authors:  E G King; H Jacobs
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

7.  The Guillain-Barré syndrome: clinical and electroneuromyographic studies.

Authors:  H Takeuchi; M Takahashi; J Kang; S Ueno; A Yamada; H Miki; S Tarui
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

8.  Nerve conduction in the Guillain-Barré-Strohl syndrome.

Authors:  I Hausmanowa-Petrusewicz; B Emeryk; K Rowińska-Marcińska; H Jedrzejowska
Journal:  J Neurol       Date:  1979-05-02       Impact factor: 4.849

9.  Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome.

Authors:  K S Tse; C E Arbesman; T B Tomasi; D Tourville
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

10.  The nosological position of Fisher's syndrome (ophthalmoplegia, ataxia and areflexia).

Authors:  F Barontini; D Sitá
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.